# Benitec Biopharma Inc.: filings

BNTC · Nasdaq · CIK 1808898 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/bntc.md) · [Financials](/companies/bntc/financials.md) · [Filings](/companies/bntc/filings.md) · [Insiders](/companies/bntc/insiders.md)

## Reports and events: 133 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 78, 4 50, SC 13G/A 21, 10-Q 18, CORRESP 18, SC 13G 15, UPLOAD 13, 3 12, EFFECT 12, DEF 14A 8, S-1/A 8, 10-K 7, 424B5 7, DEFA14A 7, S-3 7, SCHEDULE 13G/A 7, S-1 5, PRE 14A 4, S-8 4, 424B3 3, 424B4 3, 8-K/A 3, FWP 2, SC 13D/A 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, 10-K/A 1, 8-K12B 1, D 1, DEL AM 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 16:25 ET | [DEF 14A](/filings/0001193125-26-426733.md) | Proxy statement, period 2026-10-20 | 0001193125-26-426733 |
| 2026-10-05 | 08:08 ET | [8-K](/filings/0001193125-26-413177.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-413177 |
| 2026-09-30 | 16:08 ET | [8-K](/filings/0001193125-26-409052.md) | 4.01 Change of auditor | 0001193125-26-409052 |
| 2026-09-24 | 16:38 ET | [8-K](/filings/0001193125-26-401110.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-401110 |
| 2026-09-14 | 16:09 ET | [10-K](/filings/0001193125-26-390570.md) | Annual report, period 2026-06-30 | 0001193125-26-390570 |
| 2026-09-14 | 16:04 ET | [8-K](/filings/0001193125-26-390539.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-390539 |
| 2026-05-29 | 16:10 ET | [8-K](/filings/0001193125-26-248289.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-248289 |
| 2026-05-14 | 08:10 ET | [10-Q](/filings/0001193125-26-222885.md) | Quarterly report, period 2026-03-31 | 0001193125-26-222885 |
| 2026-05-14 | 08:09 ET | [8-K](/filings/0001193125-26-222879.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-222879 |
| 2026-03-20 | 16:03 ET | [10-K/A](/filings/0001193125-26-117604.md) | Annual report, amended, period 2025-06-30 | 0001193125-26-117604 |
| 2026-02-12 | 08:09 ET | [8-K](/filings/0001193125-26-047742.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-047742 |
| 2026-02-12 | 08:07 ET | [10-Q](/filings/0001193125-26-047737.md) | Quarterly report, period 2025-12-31 | 0001193125-26-047737 |
| 2025-12-02 | 17:27 ET | [8-K](/filings/0001193125-25-305475.md) | 5.07 Shareholder vote results | 0001193125-25-305475 |
| 2025-11-14 | 17:31 ET | [8-K](/filings/0001193125-25-283351.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-283351 |
| 2025-11-14 | 17:05 ET | [10-Q](/filings/0001193125-25-283274.md) | Quarterly report, period 2025-09-30 | 0001193125-25-283274 |
| 2025-11-10 | 21:53 ET | [SCHEDULE 13D/A](/filings/0000899140-25-001257.md) | Ownership report, active investor, amended | 0000899140-25-001257 |
| 2025-11-07 | 21:29 ET | [8-K](/filings/0001193125-25-270490.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-270490 |
| 2025-11-03 | 07:11 ET | [8-K](/filings/0001193125-25-261665.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-261665 |
| 2025-10-14 | 16:58 ET | [DEF 14A](/filings/0001193125-25-239131.md) | Proxy statement, period 2025-12-01 | 0001193125-25-239131 |
| 2025-09-22 | 16:53 ET | [8-K](/filings/0001193125-25-211462.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-211462 |
| 2025-09-22 | 16:23 ET | [10-K](/filings/0001193125-25-211361.md) | Annual report, period 2025-06-30 | 0001193125-25-211361 |
| 2025-09-12 | 16:11 ET | [8-K](/filings/0000950170-25-114530.md) | 4.02 Non-reliance on financial statements | 0000950170-25-114530 |
| 2025-07-09 | 16:16 ET | [8-K](/filings/0001193125-25-157095.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-157095 |
| 2025-05-14 | 08:00 ET | [8-K](/filings/0001193125-25-119402.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-119402 |
| 2025-05-14 | 07:09 ET | [10-Q](/filings/0001193125-25-119383.md) | Quarterly report, period 2025-03-31 | 0001193125-25-119383 |
| 2025-03-28 | 17:13 ET | [8-K](/filings/0001193125-25-067232.md) | 8.01 Other events | 0001193125-25-067232 |
| 2025-03-28 | 16:50 ET | [SCHEDULE 13D/A](/filings/0000899140-25-000478.md) | Ownership report, active investor, amended | 0000899140-25-000478 |
| 2025-03-27 | 17:10 ET | [8-K](/filings/0001193125-25-065613.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-065613 |
| 2025-03-26 | 08:13 ET | [8-K](/filings/0001193125-25-063235.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-063235 |
| 2025-03-20 | 17:25 ET | [8-K](/filings/0001193125-25-059398.md) | 8.01 Other events | 0001193125-25-059398 |
| 2025-03-19 | 07:18 ET | [8-K](/filings/0001193125-25-057153.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-057153 |
| 2025-02-14 | 08:19 ET | [8-K](/filings/0001193125-25-026659.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-026659 |
| 2025-02-14 | 07:51 ET | [10-Q](/filings/0001193125-25-026631.md) | Quarterly report, period 2024-12-31 | 0001193125-25-026631 |
| 2024-12-31 | 06:34 ET | [8-K/A](/filings/0001193125-24-287065.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-287065 |
| 2024-12-13 | 16:15 ET | [8-K](/filings/0001193125-24-278529.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-278529 |
| 2024-12-10 | 17:00 ET | [8-K](/filings/0001193125-24-274395.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-274395 |
| 2024-12-06 | 17:01 ET | [8-K](/filings/0001193125-24-272533.md) | 5.07 Shareholder vote results | 0001193125-24-272533 |
| 2024-11-18 | 16:36 ET | [SC 13D/A](/filings/0000899140-24-001285.md) | Ownership report, active investor, amended | 0000899140-24-001285 |
| 2024-11-14 | 16:37 ET | [8-K](/filings/0001193125-24-258694.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-258694 |
| 2024-11-14 | 16:32 ET | [10-Q](/filings/0001193125-24-258672.md) | Quarterly report, period 2024-09-30 | 0001193125-24-258672 |
| 2024-11-14 | 16:31 ET | [8-K](/filings/0001193125-24-258668.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-258668 |
| 2024-10-22 | 09:23 ET | [DEF 14A](/filings/0001193125-24-241155.md) | Proxy statement, period 2024-12-04 | 0001193125-24-241155 |
| 2024-10-15 | 08:07 ET | [8-K](/filings/0001193125-24-237227.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-237227 |
| 2024-10-11 | 16:52 ET | [8-K](/filings/0001193125-24-236782.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-236782 |
| 2024-10-08 | 16:45 ET | [8-K](/filings/0001193125-24-234458.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-234458 |
| 2024-09-30 | 17:18 ET | [SC 13D/A](/filings/0000899140-24-001043.md) | Ownership report, active investor, amended | 0000899140-24-001043 |
| 2024-09-26 | 16:43 ET | [8-K](/filings/0001193125-24-226999.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-226999 |
| 2024-09-26 | 16:30 ET | [10-K](/filings/0001193125-24-226968.md) | Annual report, period 2024-06-30 | 0001193125-24-226968 |
| 2024-09-05 | 20:37 ET | [8-K](/filings/0001193125-24-213348.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-213348 |
| 2024-07-29 | 16:28 ET | [DEF 14A](/filings/0001193125-24-187599.md) | Proxy statement, period 2024-08-29 | 0001193125-24-187599 |

Page 1 of 3. [Older](/companies/bntc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 08:04 ET. No prices; not investment advice.